Publication | Closed Access

Dexmedetomidine alleviates doxorubicin cardiotoxicity by inhibiting mitochondrial reactive oxygen species generation

InflammationDoxorubicin CardiotoxicityHeart FailureMitochondrial FunctionLipid PeroxidationPhysiologyPharmacologyCardiovascular PharmacologyPharmacotherapyReactive Oxygen SpecieCardiovascular ToxicityMedicineRedox BiologyOxidative Stress